OrganoClick AB (ORGC) AI Stock Analysis

• Market Cap: kr86.90M
• Dividend Yield: N/A
• Average Volume (3M): 87.89K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.17
• Revenue Growth: -18.29%
• EPS Growth: -48.74%
• Country: SE
• Employees: 40
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): -0.10
• Shares Outstanding: 110,003,010
• 10 Day Avg. Volume: 18,569
• 30 Day Avg. Volume: 87,893
• PEG Ratio: -0.05
• Price to Book (P/B): 11.75
• Price to Sales (P/S): 1.68
• P/FCF Ratio: -16.96
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): -0.09
• Revenue Forecast (FY): kr121.00M

• Rating: 41 Neutral
• Price Target: kr0.75 ▼(-57.64% Downside)
• Action: Upgraded Date: 04/10/26
• Date: Action: Upgraded 04/10/26

The score is weighed down primarily by weak financial performance (deepening losses, rising leverage, and ongoing cash burn). Technicals add further pressure with pronounced bearish momentum and the price far below key moving averages. Valuation provides limited offset because the negative P/E reflects unprofitability and there is no dividend yield data.

Positive Factors

Sustainable bio-based technology platform

OrganoClick’s core platform is bio-based chemical technologies for material modification. That product-level IP aligns with long-term regulatory and brand shifts toward lower-toxicity, renewable chemistries, supporting durable demand from industrial customers seeking sustainable inputs and potential licensing opportunities.

Negative Factors

Persistent net losses and widening margins

The company has been loss-making with a sharp deterioration to ~-34% net margin in 2025. Persistent operating losses erode equity, limit reinvestment capacity, and make the business reliant on external funding until structural revenue and cost improvements are realized.

OrganoClick AB Business Overview & Revenue Model

Company Description

OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals for treatment of wood, technical textile and nonwoven, and bio composites in Sweden. It offers OrganoWood, a woo...

Read more

OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals for treatment of wood, technical textile and nonwoven, and bio composites in Sweden. It offers OrganoWood, a woo...

How the Company Makes Money

OrganoClick makes money primarily by selling chemical products and formulations based on its bio-based technology platform to industrial customers, and by selling branded consumer products through retail and e-commerce channels. Its revenue model ...

Read more

OrganoClick makes money primarily by selling chemical products and formulations based on its bio-based technology platform to industrial customers, and by selling branded consumer products through retail and e-commerce channels. Its revenue model ...

OrganoClick AB Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	106.19M	127.23M	145.87M	115.05M	110.06M
Gross Profit	14.86M	31.84M	35.39M	12.94M	18.51M
EBITDA	-12.80M	5.71M	5.95M	-21.19M	-12.92M
Net Income	-36.37M	-17.97M	-15.77M	-41.62M	-31.03M
Balance Sheet
Total Assets	135.22M	126.98M	150.75M	162.86M	188.39M
Cash, Cash Equivalents and Short-Term Investments	2.68M	538.00K	10.74M	15.20M	34.25M
Total Debt	77.78M	51.67M	62.39M	61.68M	53.54M
Total Liabilities	114.81M	89.15M	97.34M	95.30M	80.66M
Stockholders Equity	15.18M	28.98M	44.58M	58.78M	100.33M
Cash Flow
Free Cash Flow	-10.51M	-5.51M	-8.08M	-35.35M	-52.34M
Operating Cash Flow	-8.29M	3.60M	533.00K	-21.22M	-37.69M
Investing Cash Flow	-10.99M	-9.11M	-8.61M	-7.45M	-14.65M
Financing Cash Flow	21.42M	-4.69M	3.60M	9.63M	54.56M

OrganoClick AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.78
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ORGC, the sentiment is Negative. The current price of 1.78 is above the 20-day moving average (MA) of 1.23, above the 50-day MA of 1.47, and above the 200-day MA of 1.70, indicating a bearish trend. The MACD of -0.22 indicates Positive momentum. The RSI at 15.42 is Positive, neither overbought nor oversold. The STOCH value of 5.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ORGC.

OrganoClick AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
NEXAM	55 Neutral	kr277.76M	-12.04	-9.48%	―	-1.89%	-59.17%
POLYG	55 Neutral	kr271.76M	-23.68	-7.45%	2.89%	7.92%	94.99%
AERO	47 Neutral	kr42.03M	-0.99	-75.93%	0.00%	―	―
XPC	47 Neutral	kr57.61M	-4.19	―	―	―	―
IMPC	44 Neutral	kr141.52M	-2.70	―	―	―	―
ORGC	41 Neutral	kr86.90M	-4.90	-153.91%	―	-18.29%	-48.74%